DRKS00010283招募中不适用
Isolation of hematopoietic stem cells from placenta and cord blood to generate a humanized mouse model - IsoNaP
abor für experimentelle ImmunologieKlinik I für Innere Medizin, Zentrum für Molekulare Medizin0 个研究点目标入组 300 人开始时间: 2016年8月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Female
入选标准
- •written informed consent
排除标准
- •diseases of the hematopoietic system; infectious diseases
研究者
相似试验
已完成
不适用
Allogeneic hematopoietic stem cell transpalntation using Thymoglobulin for patients with T-cell malignancyT-cell malignancyJPRN-UMIN000015736ational Cancer Center Hospital15
招募中
不适用
Are circulating hematopoietic stem and progenitor cells a potential biomarker for therapy response and disease progression in patients with squamous cell carcinoma of the head and neck?NL-OMON46829Antoni van Leeuwenhoek Ziekenhuis30
进行中（未招募）
1 期
Stem cells transplant from matched donor in patients with chronic myeloid leukemia who do not improve with TKI therapyChronic Myeloid LeukemiaMedDRA version: 18.0Level: LLTClassification code 10054352Term: Chronic phase chronic myeloid leukemiaSystem Organ Class: 100000004864EUCTR2014-003126-40-ITIVERSITà DEGLI STUDI MILANO BICOCCA20
已完成
1 期
Haploidentical hematopoietic stem cell transplantation in combination with posttransplant cyclophosphamide and ATG-thymoglobulin Phase I studyhematological malignancyJPRN-UMIN000009374ational Cancer Center Hospital15
已完成
1 期
Haploidentical hematopoietic stem cell transplantation with posttransplant cyclophosphamide in combination with thymoglobulin (RIC version) Phase IHematological malignancyJPRN-UMIN000011004ational Cancer Center Hospital12